GZGuangjun Zhang

Guangjun Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Guangjun Zhang has a total of 58 co-authors. Here are the top co-authors by number of shared publications:

  • Hongpeng Tian

    Second Department of Gastrointestinal Surgery, Hepatobiliary, Pancreatic and Intestinal Diseases Research Institute,The Affiliated Hospital of North Sichuan Medical College, National Clinical Key Specialty (General Surgery), Sub-center of National Clinical Research Center for Digestive Diseases, Sichuan Clinical Research Center for Digestive Diseases, China

    8 shared publications
  • Tong Zhou

    Second Department of Gastrointestinal Surgery, The Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, China

    6 shared publications
  • Zaihua Yan

    Department of Gastrointestinal Surgery, Affiliated Hospital of North Sichuan Medical College/Institute of Hepatobiliary Pancreatic and Intestinal Disease, North Sichuan Medical College Nanchong, Sichuan, China

    6 shared publications
  • Tong Zhou

    The Second Department of General Surgery, The Affiliated Hospital of the North Sichuan Medical College, Nanchong, 637000 Sichuan, China

    5 shared publications
  • He Zhou

    The First Department of General Surgery, The Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, People’s Republic of China

    4 shared publications
  • Hua-Xu Xiao

    Department of Pathology, The North Sichuan Medical College, Nanchong, Sichuan, People’s Republic of China

    4 shared publications

Latest Publications

  • Open Access

    Tertiary lymphoid structures in luminal gastrointestinal cancers: biological circuits, spatial architecture, and biomarkers in the perioperative immunotherapy era

    by Songlin Sun, Jiahan Chen, Yang Zhong, Yihuan Luo, Guangjun Zhang

    Tertiary lymphoid structures (TLS) are inducible, organized lymphoid clusters that recapitulate key functions of secondary lymphoid organs within chronically inflamed tumor tissue. In colorectal, gastric, and esophageal cancers, the most common luminal gastrointestinal (GI) malignancies, surgical resection preserves the spatial relationship between TLS and the tumor core, invasive margin, and surrounding mucosa, making the resected specimen a uniquely informative anchor for studying antitumor immunity. This narrative review synthesizes evidence from human cohorts, single-cell and spatial genomics, and perioperative immunotherapy trials. We trace the developmental continuum from loose lymphocytic clusters to germinal center-bearing follicles, contrast germinal center-dependent humoral immunity with germinal center-independent B-cell responses, and examine how regulatory T and B cells can turn TLS into immunosuppressive niches. We then analyze proposed inductive circuits, including chemokine-stromal organization, microbial and mutational antigenic pressure, and innate immune sensing, and discuss how desmoplasia, mechanical compression, hypoxia, and metabolic competition may arrest TLS maturation. A tumor-by-tumor comparison of colorectal, gastric, and esophageal cancers shows that TLS density, maturity, and anatomic localization carry divergent prognostic information; and diffuse gastric cancer, peritoneal metastases, and chemoradiated esophageal tumors illustrate states of TLS disruption. We also appraise neoadjuvant checkpoint trials (NICHE, NICHE-2, NEONIPIGA, CheckMate 577, MATTERHORN), consider TLS as complements to TNM staging for adjuvant decision-making and as candidate correlates of pathologic response, and outline experimental strategies for TLS induction and the technical prerequisites for translating TLS into surgical biomarkers. We hypothesize that mature, margin-positioned TLS are promising development- and location-dependent markers of organized antitumor immunity, but routine clinical use awaits standardized, multicenter validation. We therefore propose a minimum reporting framework to accelerate this translation.

  • Open Access

    Multi-cohort integration and machine learning identify CPVL as a novel oncogenic driver in gastric cancer

    by Xin Li, Jiahan Chen, Hongpen Tian, Guangjun Zhang

    Gastric cancer (GC) remains a leading cause of cancer-related mortality worldwide, and the prognosis of advanced GC remains poor. Systematic identification of robust biomarkers through multi-cohort integration and computational prioritization may facilitate the discovery of novel therapeutic targets. To identify key genes associated with gastric cancer progression through integrative multi-omics analysis and to elucidate the biological functions and molecular mechanisms of the top-prioritized candidate gene. Comprehensive bioinformatics analyses integrating The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx), and Gene Expression Omnibus (GEO) datasets were performed using differential expression analysis, weighted gene co-expression network analysis (WGCNA), Cox regression, and eight machine-learning algorithms to systematically identify and prioritize GC-associated hub genes. Among the identified candidates, CPVL was selected for further validation based on its diagnostic and prognostic performance. CPVL expression and clinical relevance were validated by independent datasets and immunohistochemistry. Lentiviral constructs were used to overexpress or silence CPVL in GC cell lines. Functional assays were performed, including CCK-8, colony formation, EdU incorporation, and flow cytometry, to assess cell proliferation and cell-cycle distribution. Western blotting and JAK2 inhibitor (AZD1480) rescue experiments were performed to elucidate the underlying mechanisms, and a nude mouse xenograft model was used to evaluate tumorigenicity in vivo. Multi-cohort screening identified five hub genes (CPVL, AADAC, BCAT1, CPXM1, and FBN1). Among them, CPVL exhibited the highest diagnostic accuracy (AUC = 0.895) and the strongest correlation with poor overall survival, and was therefore selected for mechanistic investigation. CPVL expression was markedly upregulated in GC tissues and cell lines. Functional assays demonstrated that CPVL promotes GC cell proliferation and accelerates G1/S-phase transition. Mechanistically, CPVL activated the JAK2/STAT3 signaling pathway, upregulating Cyclin D1 and CDK4 while downregulating p27. Treatment with the JAK2 inhibitor AZD1480 partially reversed these effects. In vivo, CPVL knockdown significantly inhibited tumor growth. Through systematic multi-cohort integration and machine-learning prioritization, CPVL was identified as a novel oncogenic driver in gastric cancer. CPVL promotes tumor growth via activation of the JAK2/STAT3 pathway and regulation of the Cyclin D1/CDK4/p27 axis, highlighting its potential as a diagnostic biomarker and therapeutic target.

  • Top Cited Papers
    Open Access

    The gut microbiome in colorectal anastomotic leakage: from mechanisms to precision

    by Songlin Sun, Feng Long, Bowen Su, Jiahan Chen, Yihuan Luo, Yang Zhong, Guangjun Zhang

    Anastomotic leakage after curative colorectal cancer resection remains a frequent and severe complication that increases short-term mortality, worsens long-term oncologic outcomes, and places substantial burdens on individuals and health systems despite advances in surgical technique and perioperative care. Emerging evidence redefines anastomotic failure as not only a technical event but also a biologically driven process in which the gut microbiome regulates inflammation, epithelial repair, and barrier integrity at the healing interface. This review summarizes current data on the dual role of the intestinal microbiome in promoting physiological anastomotic healing and driving pathological leakage when perioperative stressors cause dysbiosis. Mechanistic sections describe how a diverse, metabolically active community supports collagen stability through short-chain fatty acid production, immune regulation, and maintenance of mucus and tight junction architecture. In contrast, the enrichment of microbial groups such as Enterococcus faecalis , Fusobacterium nucleatum , and Alistipes onderdonkii together with fungal and viral shifts, has been associated with extracellular matrix degradation and excessive inflammation. Furthermore, the review examines microbiome-related biomarkers for risk assessment, including DNA-based microbial signatures, metabolite profiles, and host immune markers. It also discusses how integrated multi-omics models combined with machine learning may outperform traditional clinical scores for preoperative and early postoperative prediction. Finally, the article critically evaluates perioperative microbiome-directed strategies ranging from dietary prehabilitation and microbial supplementation to selective decontamination and fecal microbiota transplantation, highlighting promising signals, variability of effect, safety considerations, and key methodological limitations that currently prevent routine implementation. In summary, this review addresses three interconnected domains—mechanisms of microbiome-driven anastomotic failure, microbiome-derived biomarkers for risk stratification, and perioperative intervention strategies—underscoring that AL is best understood as a host–microbiome interaction rather than a purely technical failure. This framing offers surgeons and perioperative teams a biologically rational basis for prevention, yet clinical translation will require causal validation, standardized intervention algorithms, and interpretable computational tools embedded into real-world perioperative practice.


  • Open Access

    Laparoscopic right hemicolectomy in situs inversus totalis with cecal carcinoma: a case report and literature review

    by Bowen Su, Yang Zhong, Jiahan Chen, Hongpeng Tian, Tianhao Wu, Guangjun Zhang

    Background: Our patient exhibited situs inversus totalis (SIT)—a developmental quirk resulting in right–left transposition of all visceral organs, including the heart, liver, and spleen. While prior case reports have described colorectal carcinoma in individuals with SIT, to our knowledge, this case represents an exceptionally rare presentation of primary cecal carcinoma within this anatomical context. This case describes a patient undergoing laparoscopic right hemicolectomy for adenocarcinoma of the cecum. Case presentation: A patient presented to our institution in May 2024. Subsequent diagnostic workup confirmed a diagnosis of cecal carcinoma. Given the absolute contraindication for bowel preparation secondary to complete bowel obstruction, along with radiologically confirmed cecal malignancy and elevated serum tumor markers, a multidisciplinary consensus was reached to proceed with laparoscopic right hemicolectomy after obtaining proper informed consent from the patient’s family. Pathology confirmed a T3N0M0 well-differentiated adenocarcinoma. Twelve-month consecutive postoperative follow-up data confirmed the absence of surgical complications such as anastomotic leakage or infection, as well as no clinical or radiographic evidence of disease recurrence. Conclusion: Although the reversed anatomy in SIT patients presents inherent technical challenges for laparoscopic surgery, this minimally invasive approach can still achieve comparable safety and efficacy to conventional procedures when performed by experienced surgeons with adequate anatomical understanding.


  • Splicing factor 3b subunit 4 (SF3b4) is mediated by EP300 and CREBBP to promote colorectal cancer (CRC) proliferation by enhancing autophagy

    by Tianhao Wu, Zhongxiang Xiao, Bowen Su, Zaihua Yan, Yv Zhao, Cheng Huang, Lu Zhou, Hongpeng Tian, Guangjun Zhang

    Splicing factor 3b subunit 4 (SF3b4) is closely associated with cancer development. As a core subunit of the SF3b complex, SF3b4 participates in regulating alternative splicing, and its abnormal expression is linked to the onset of malignant tumors. However, the role of SF3b4 in colorectal cancer (CRC) remains undefined. This study demonstrates that in CRC, E1A binding protein p300 (EP300) and CREB binding protein (CREBBP) regulate SF3b4 expression by activating Histone H3 lysine 27 acetylation (H3K27ac) on the SF3b4 promoter. Additionally, enhanced autophagy counteracts the proliferation-inhibitory effect of SF3b4 knockdown in CRC cells. Implications Statement: SF3b4 may promote CRC proliferation by enhancing cellular autophagy. SF3b4 acts as a potential oncogene in CRC tumorigenesis and progression. SF3b4 serves as a promising prognostic biomarker for CRC.


  • Open Access

    Estrogen inhibits colonic smooth muscle contractions by regulating BKβ1 signaling

    by Jing Wen, Yu Zhao, Cheng Huang, Shengjie Li, Peidong Li, Yu Zhou, Zaihua Yan, Guangjun Zhang

    The estrogen inhibits colonic smooth muscle contractions, which may lead to constipation. However, the mechanisms of inhibition are poorly understood. Therefore, the present study examined the effect of estrogen on rat colonic smooth muscle contractions and its potential association with the large-conductance Ca2+-activated K+ channels β1 (BKβ1) subunit. Twenty-four female Sprague Dawley rats were randomly assigned to 4 groups. After 2 weeks of intervention, the contraction activity of isolated colonic smooth muscle and the expression of BKβ1 in colonic smooth muscle of rats were detected. Additionally, in order to investigate the effects of estrogen on BKβ1 expression and calcium mobilization, in vitro experiments were conducted using rat and human colonic smooth muscle cells (SMCs). BKβ1 shRNA was used to investigate whether calcium mobilization is affected by BKβ1 in colonic SMCs. To explore the relationship between ERβ and BKβ1, serial deletions, site-directed mutagenesis, a dual-luciferase reporter assay, and chromatin immunoprecipitation assays were employed. In response to E2, colonic smooth muscle strips showed a decrease in tension, while IBTX exposure transiently increased tension. Furthermore, in these muscle tissues, BKβ1 and α-SMA were found to be co-expressed. The E2 group showed significantly higher BKβ1 expression. In cultured colonic SMCs, the expression of BKβ1 was found to increase in the presence of E2 or DPN. E2 treatment reduced Ca2+ concentrations, while BKβ1 shRNA treatment increased Ca2+ concentrations relative to the control. ERβ-initiated BKβ1 expression appears to occur via binding to the BKβ1 promoter. These results indicated that E2 may upregulate BKβ1 expression via ERβ and inhibit colonic smooth muscle contraction through ERβ by directly targeting BKβ1.


  • Open Access

    miR-22 Suppresses EMT by Mediating Metabolic Reprogramming in Colorectal Cancer through Targeting MYC-Associated Factor X

    by Shusen Xia, Xianyan Wang, Yi Wu, Tong Zhou, Hongpeng Tian, Zuoliang Liu, Lifa Li, Zaihua Yan, Guangjun Zhang

    Colorectal cancer (CRC) is one of the most frequent gastrointestinal cancers. MicroRNAs (miRNAs) have been proved to be unusually expressed in CRC progression and thus alter multiple pathological processes in CRC cells. However, the specific roles and mechanisms of miR-22 in CRC have not been clearly reported. MicroRNA-22 (miR-22) and MYC-associated factor X (MAX) expressions were determined by RT-qPCR in CRC tissues and cells. The targeted regulatory effects of miR-22 and MAX were confirmed by luciferase reporter and coimmunoprecipitation assays. Also, gain- and loss-of-function and rescue experiments were used to elucidate the function and mechanism of miR-22 and MAX in CRC cells and the mouse xenograft model. We discovered that miR-22 was hypermethylated and downregulated, while MAX was upregulated in CRC. miR-22 markedly inhibited migration, invasion, glycolysis, and cancer stem cell transcription factors in CRC cells. In addition, it was found that miR-22 can directly target MAX. Additional functional experiments confirmed that MAX overexpression can rescue the effects of miR-22 on the behavior of CRC cells. This study suggested that miR-22, as a cancer suppressor, participates in CRC progression by targeting MAX, which might provide basic information for therapeutic targets for CRC.


  • Open Access

    Zinc finger protein 384 enhances colorectal cancer metastasis by upregulating MMP2

    by Zaihua Yan, Yu Zhou, Yang Yang, Chongpu Zeng, Peidong Li, Hongpeng Tian, Xuegui Tang, Guangjun Zhang

    Zinc finger proteins (ZNFs) serve key roles in tumor formation and progression; however, the functions and underlying mechanisms of dysregulated ZNF384 in colorectal cancer (CRC) are yet to be fully elucidated. Therefore, the present study initially aimed to investigate the expression levels of ZNF384 in CRC samples. Moreover, lentiviral ZNF384 overexpression and ZNF384 knockdown models were established in CRC cells. Transwell, wound healing and in vivo tail vein metastasis assays were carried out to evaluate the effects of ZNF384 on CRC cell metastasis. Furthermore, reverse transcription‑quantitative PCR, western blotting, serial deletion, site‑directed mutagenesis, dual‑luciferase reporter and chromatin immunoprecipitation assays were conducted to investigate the potential underlying mechanisms. The results of the present study demonstrated that ZNF384 expression was markedly increased in CRC samples and this was associated with a poor prognosis. Notably, ZNF384 overexpression increased the levels of CRC cell invasion and migration, whereas ZNF384 knockdown inhibited CRC development. Moreover, the results of the present study demonstrated that ZNF384 mediated the expression of MMP2. MMP2 knockdown inhibited ZNF384‑mediated CRC cell invasion and migration, whereas MMP2 overexpression ameliorated ZNF384 knockdown‑induced inhibition of CRC progression. In addition, the results of the present study demonstrated that hypoxia‑inducible factor 1α (HIF‑1α) had the ability to bind to the ZNF384 promoter, thereby initiating ZNF384 expression. In human‑derived CRC samples, the expression levels of ZNF384 were positively correlated with both MMP2 and HIF‑1α expression. Collectively, these findings highlighted that ZNF384 may act as a prognostic marker and regulator of CRC metastasis.


  • Open Access

    MicroRNA‑23b‑3p targets non‑SMC condensing I complex subunit G to promote proliferation and inhibit apoptosis of colorectal cancer cells via regulation of the PI3K/AKT signaling pathway

    by Peidong Li, Jing Wen, Xiru Ren, Yu Zhou, Yuan Xue, Zaihua Yan, Shengjie Li, Hongpeng Tian, Xue-Gui Tang, Guang-Jun Zhang

    Colorectal cancer (CRC) is one of the most common types of malignancy worldwide and has a poor prognosis. Non‑SMC condensing I complex subunit G (NCAPG) has been reported to be upregulated in numerous types of malignant tumor. However, to the best of our knowledge, its clinicopathological and biological significance in CRC remain to be elucidated. The results of the present study revealed that NCAPG expression levels were upregulated in human CRC tissues and cell lines. The upregulated expression of NCAPG was positively associated with patient clinicopathological characteristics, such as differentiation and tumor size, and independently associated with poor survival. Consistent with the clinical observations, NCAPG was discovered to promote the proliferation and inhibit the apoptosis of CRC cells. Moreover, NCAPG‑knockdown inhibited CRC cell proliferation by regulating the PI3K/AKT signaling pathway. Furthermore, NCAPG was identified as a potential target of microRNA (miR)‑23b‑3p, which was subsequently demonstrated to negatively regulate NCAPG expression. In conclusion, the findings of the current study indicated that the miR‑23b‑3p/NCAPG/PI3K/AKT signaling axis may play an important role in CRC carcinogenesis, and the status of the molecule may represent a promising prognostic marker for the disease.


  • Open Access

    Glutamate receptor, ionotropic, N‑methyl D‑aspartate‑associated protein 1 promotes colorectal cancer cell proliferation and metastasis, and is negatively regulated by miR‑296‑3p

    by Zaihua Yan, Peidong Li, Yuan Xue, Hongpeng Tian, Tong Zhou, Guangjun Zhang

    N‑methyl D‑aspartate receptors (NMDARs) are closely associated with the development, growth and metastasis of cancer. Glutamate receptor, ionotropic, N‑methyl D‑aspartate‑associated protein 1 (GRINA) is a member of the of the NMDAR family, and its aberrant expression is associated with gastric cancer. However, the role of GRINA in colorectal cancer (CRC) is not completely understood. In the present study, expression profiles of GRINA in several CRC databases were obtained and further verified using clinical CRC samples. The effects of GRINA overexpression on CRC progression both in vivo and in vitro were assessed. Briefly, cell proliferation was detected using MTT assay, and cell migration and invasion ability were evaluated by wound healing and Transwell assay. In addition, the molecular mechanism underlying the upregulated expression of GRINA in CRC was investigated. The regulatory association between GRINA and miR‑296‑3p was detected by luciferase assay, reverse transcription‑quantitative PCR and western blotting. The results demonstrated that GRINA expression levels were significantly increased in tumor samples compared with those in healthy samples, and upregulated expression of GRINA was associated with a less favorable prognostic outcome in patients with CRC. GRINA overexpression significantly increased CRC cell proliferation, invasion and migration. Additionally, it was determined that GRINA was post‑transcriptionally regulated by microRNA (miR)‑296‑3p. Together, the results of the present study suggested the potential importance of the miR‑296‑3p/GRINA axis and highlighted potential novel targets for the management of CRC.